Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.55 USD | +0.31% | +29.04% | +34.64% |
03:51pm | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.64% | 2.31B | |
-2.49% | 12.64B | |
-0.47% | 8.46B | |
+8.32% | 5.66B | |
+24.45% | 5.27B | |
-2.03% | 4.49B | |
-51.43% | 3.11B | |
+19.30% | 2.87B | |
-3.55% | 1.89B | |
+5.37% | 1.64B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Insider Sell: Myriad Genetics